Eptifibatide non cyclic impurity

Eptifibatide non cyclic impurity structure

CAS No.: 135900-78-6

Chemical Name:: Eptifibatide non cyclic impurity

Synonyms: Eptifibatide Impurity 10;Eptifibatide non cyclic impurity;L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-

CBNumber:: CB29436006

Molecular Formula:: C35H51N11O9S2

Molecular Weight:: 833.98

MDL Number:

MOL File:: 135900-78-6.mol

Request For Quotation

Eptifibatide non cyclic impurity Properties

Density	1.55±0.1 g/cm3(Predicted)
pka	4.20±0.10(Predicted)

Eptifibatide non cyclic impurity Preparation Products And Raw materials

Raw materials

Preparation Products

Eptifibatide non cyclic impurity Suppliers

Global( 7)Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
Moxin Chemicals	+86-17320513646 +8617320513646	anna@molcoo.com	China	10000	58
Hubei Yangxin Medical Technology Co., Ltd.	15374522761	3003392093@yongstandards.com	China	9996	55
Shenzhen Excellent Biomedical Technology Co., Ltd.	0755-26050679 18318671572	2850803126@qq.com	China	10000	58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd	18162595016; 18162595016	3287908757@qq.com	China	9119	58
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd	18102736234	2208093734@qq.com	China	8204	58
Hubei Molcoo Biotechnology Co., Ltd	17320513646 17320513646;	anna@molcoo.com	China	3490	58

Supplier	Advantage
Moxin Chemicals	58
Hubei Yangxin Medical Technology Co., Ltd.	55
Shenzhen Excellent Biomedical Technology Co., Ltd.	58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd	58
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd	58
Hubei Molcoo Biotechnology Co., Ltd	58

135900-78-6(Eptifibatide non cyclic impurity)Related Search:

L-Aspartic acid, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-, (1→3')-disulfide with L-tryptophyl-L-prolyl-L-cysteinamide (9CI) Eptifibatide impurity 3/Deamidated Eptifibatide Impurity/(3R,11S,17S,20S,25aS)-20-((1H-indol-3-yl)Methyl)-17-(carboxymethyl)-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosine-3-carbo Cyclo(L-Pro-L-Trp-) L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, bimol. cyclic (1→1'),(6→6')-bis(disulfide) N-[2-(Phenylmethyl)phenyl]-2-chloroacetamide

Acetamide, 2-methoxy-N-[2-(phenylmethyl)phenyl]- Methanone, (2-aminophenyl)phenyl-, hydrazone, (Z)- L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→7)-disulfide (9CI) Benzamide, N-[(6,11-dihydro-5H-dibenz[b,e]azepin-6-yl)methyl]-2-(hydroxymethyl)- 7-Bromo Epinastine

3'-Hydroxyacetophenone 6-Chloromethylmorphanthridine Acetamide, 2-(1-methylethoxy)-N-[2-(phenylmethyl)phenyl]-

1of3

Eptifibatide non cyclic impurity L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl- Eptifibatide Impurity 10 135900-78-6